Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_assertion type Assertion NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_head.
- NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_assertion description "[Both plasma and CSF in patients with relapsing/remitting MS and marked gadolinium enhancement contained the two major molecular species of PAF: 1-0-hexadecyl- (C16:O) and 1-0-octadecyl-sn-glycero-3-phosphocholine (C18:O).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_provenance.
- NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_assertion evidence source_evidence_literature NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_provenance.
- NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_assertion SIO_000772 10376955 NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_provenance.
- NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_assertion wasDerivedFrom befree-20140225 NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_provenance.
- NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_assertion wasGeneratedBy ECO_0000203 NP569226.RAtCpGShdNaBTE9g8hJc36ino36w673O-VjfyUqgmbPBc130_provenance.